Suppr超能文献

通过算法、分子对接和分子动力学模拟相结合预测人类 STK11 基因的有害非同义 SNPs。

Prediction of Deleterious Non-synonymous SNPs of Human STK11 Gene by Combining Algorithms, Molecular Docking, and Molecular Dynamics Simulation.

机构信息

Division of Computer-Aided Drug Design, The Red-Green Research Centre, BICCB, 218 Elephant Road, Dhaka, 1205, Bangladesh.

Department of Biochemistry and Biotechnology, University of Science and Technology Chittagong (USTC), Foy's Lake, Khulshi- 4202, Chittagong, Bangladesh.

出版信息

Sci Rep. 2019 Nov 11;9(1):16426. doi: 10.1038/s41598-019-52308-0.

Abstract

Serine-threonine kinase11 (STK11) is a tumor suppressor gene which plays a key role in regulating cell growth and apoptosis. It is widely known as a multitasking kinase and engaged in cell polarity, cell cycle arrest, chromatin remodeling, energy metabolism, and Wnt signaling. The substitutions of single amino acids in highly conserved regions of the STK11 protein are associated with Peutz-Jeghers syndrome (PJS), which is an autosomal dominant inherited disorder. The abnormal function of the STK11 protein is still not well understood. In this study, we classified disease susceptible single nucleotide polymorphisms (SNPs) in STK11 by using different computational algorithms. We identified the deleterious nsSNPs, constructed mutant protein structures, and evaluated the impact of mutation by employing molecular docking and molecular dynamics analysis. Our results show that W239R and W308C variants are likely to be highly deleterious mutations found in the catalytic kinase domain, which may destabilize structure and disrupt the activation of the STK11 protein as well as reduce its catalytic efficiency. The W239R mutant is likely to have a greater impact on destabilizing the protein structure compared to the W308C mutant. In conclusion, these mutants can help to further realize the large pool of disease susceptibilities linked with catalytic kinase domain activation of STK11 and assist to develop an effective drug for associated diseases.

摘要

丝氨酸/苏氨酸激酶 11(STK11)是一种肿瘤抑制基因,在调节细胞生长和凋亡方面发挥着关键作用。它被广泛认为是一种多功能激酶,参与细胞极性、细胞周期停滞、染色质重塑、能量代谢和 Wnt 信号转导。STK11 蛋白高度保守区域单个氨基酸的取代与 Peutz-Jeghers 综合征(PJS)有关,PJS 是一种常染色体显性遗传疾病。STK11 蛋白的异常功能仍不清楚。在这项研究中,我们使用不同的计算算法对 STK11 中的疾病易感单核苷酸多态性(SNP)进行了分类。我们鉴定了有害的非编码 SNP,构建了突变蛋白结构,并通过分子对接和分子动力学分析评估了突变的影响。研究结果表明,W239R 和 W308C 变体可能是催化激酶结构域中发现的高度有害突变,可能破坏结构并抑制 STK11 蛋白的激活,降低其催化效率。与 W308C 突变体相比,W239R 突变体更有可能破坏蛋白结构。总之,这些突变体有助于进一步认识与 STK11 催化激酶结构域激活相关的大量疾病易感性,并有助于开发相关疾病的有效药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6235/6848484/685725fe3dc4/41598_2019_52308_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验